MX2007005336A - Analgesicos. - Google Patents

Analgesicos.

Info

Publication number
MX2007005336A
MX2007005336A MX2007005336A MX2007005336A MX2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A
Authority
MX
Mexico
Prior art keywords
analgesic
various
compound
active ingredient
acid addition
Prior art date
Application number
MX2007005336A
Other languages
English (en)
Spanish (es)
Inventor
Hiroshi Nagabukuro
Tadatoshi Hashimoto
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of MX2007005336A publication Critical patent/MX2007005336A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007005336A 2004-11-04 2005-11-04 Analgesicos. MX2007005336A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04
PCT/JP2005/020297 WO2006049248A1 (ja) 2004-11-04 2005-11-04 鎮痛剤

Publications (1)

Publication Number Publication Date
MX2007005336A true MX2007005336A (es) 2007-06-25

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005336A MX2007005336A (es) 2004-11-04 2005-11-04 Analgesicos.

Country Status (12)

Country Link
US (1) US8470845B2 (enExample)
EP (1) EP1820505A4 (enExample)
JP (1) JP4706636B2 (enExample)
KR (1) KR101285645B1 (enExample)
CN (1) CN101090722B (enExample)
AR (1) AR053098A1 (enExample)
CA (1) CA2586181C (enExample)
MX (1) MX2007005336A (enExample)
NO (1) NO20072832L (enExample)
PE (1) PE20060723A1 (enExample)
TW (1) TW200621785A (enExample)
WO (1) WO2006049248A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200806294A (en) * 2005-11-09 2008-02-01 Toray Industries Therapeutic or prophylactic agent for functional intestinal injury
CA2634055C (en) 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
CA2687956C (en) * 2007-05-21 2015-03-31 Toray Industries, Inc. Method for producing pharmaceutical tablet
WO2008143240A1 (ja) * 2007-05-21 2008-11-27 Toray Industries, Inc. 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
JP5564943B2 (ja) * 2007-05-21 2014-08-06 東レ株式会社 結晶性微粉化粒子
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
CA3091752A1 (en) 2018-03-08 2019-09-12 Victoria Link Ltd Treatment of demyelinating diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (enExample) * 1964-02-03 1966-10-31
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
NZ268969A (en) 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
JP3348230B2 (ja) 1995-03-03 2002-11-20 アルゴス ファーマシューティカル コーポレーション 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用
AU6020300A (en) 1999-07-19 2001-02-05 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
ATE292625T1 (de) 2000-10-31 2005-04-15 Rensselaer Polytech Inst 8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
CN100537573C (zh) * 2002-10-09 2009-09-09 东丽株式会社 尿频或尿失禁的治疗或预防剂以及具有含氮环状取代基的吗啡烷衍生物
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
DE602005011113D1 (de) 2004-03-30 2009-01-02 Toray Industries Morphinanderivate als mittel gegen juckreiz

Also Published As

Publication number Publication date
KR20070085436A (ko) 2007-08-27
CN101090722A (zh) 2007-12-19
WO2006049248A1 (ja) 2006-05-11
CA2586181A1 (en) 2006-05-11
JPWO2006049248A1 (ja) 2008-08-07
EP1820505A1 (en) 2007-08-22
CA2586181C (en) 2012-11-27
EP1820505A4 (en) 2010-01-20
JP4706636B2 (ja) 2011-06-22
PE20060723A1 (es) 2006-08-29
HK1115808A1 (en) 2008-12-12
US20070299100A1 (en) 2007-12-27
NO20072832L (no) 2007-08-01
KR101285645B1 (ko) 2013-07-12
TWI356826B (enExample) 2012-01-21
TW200621785A (en) 2006-07-01
US8470845B2 (en) 2013-06-25
CN101090722B (zh) 2011-12-21
AR053098A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
MY147211A (en) Novel dihydropseudoerythromycin derivatives
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
TW200615266A (en) Organic compounds
WO2009060835A1 (ja) 新規ユビキリン結合性小分子
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
TNSN08407A1 (en) Organic compounds
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
WO2004056827A3 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
TW200744588A (en) Pharmaceutical composition for external use
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
TW200714583A (en) Substituted gamma lactams as therapeutic agents
TW200612958A (en) Substituted imidazole derivatives
BRPI0507617A (pt) antagonistas de receptor de quimiocina
TW200626558A (en) Indazolone derivatives
WO2008153159A1 (ja) アミン化合物及びその医薬用途
WO2007146856A3 (en) Substituted gamma lactams as therapeutic agents
WO2008139845A8 (ja) 新規アミド誘導体
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
WO2005092304A3 (en) Antifungal agents
MX2009001578A (es) Lactamas terapeuticas.
WO2007005941A3 (en) Liver targeted conjugates
TW200621785A (en) Analgesic
GB0212410D0 (en) Organic compounds
TW200733963A (en) Cough inhibitor

Legal Events

Date Code Title Description
FG Grant or registration